Video

Dr. Stevenson on the Importance of Early Screening in Lung Cancer

James Stevenson, MD, discusses the importance of early screening in lung cancer.

James Stevenson, MD, medical oncologist and hematologist, Department of Hematology and Medical Oncology, Cleveland Clinic, discusses the importance of early screening in lung cancer. 

Chest CT screening for lung cancer is an easy strategy to detect potentially cancerous nodules, Stevenson says. Being able to detect potentially cancerous nodules is the goal of any type of cancer screening that is completed in the early-stage setting when patients may be asymptomatic, Stevenson explains.

Additional data are likely to emerge regarding larger screening programs, which will reveal the percentage of small cell lung cancer vs non–small cell lung cancer vs other cancer types that are detected through screening. Moreover, data may indicate whether screening can lead to a stage migration in lung cancer where a higher percentage of patients are being diagnosed at earlier stages, Stevenson concludes.

Related Videos
Ben Levy, MD, and Yan Leyfman, MD
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
BDTX-1535 – A MasterKey EGFR Inhibitor Targeting Classical, Non-Classical, and the C797S Resistance Mutation To Address The Evolved Landscape Of EGFR Mutant NSCLC
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic